European Organisation for Research and Treatment of Cancer (EORTC) shared a post on LinkedIn by touchMEDICAL, adding:
“What are the priorities of EORTC’s new President, Prof. Benjamin Besse?
In this interview with Touch Oncology, Prof. Besse shares his vision for the future of academic clinical cancer research, from supporting the next generation of researchers and strengthening patient involvement to advancing quality of life research and harnessing the potential of AI.”
Quoting touchMEDICAL:
“What does the future hold for academic cancer research?
Professor Benjamin Besse, President of the EORTC – European Organisation for Research and Treatment of Cancer discusses his priorities for advancing cancer research while keeping patients at the centre.
In this Q&A, he explores the need for more representative clinical trials, greater emphasis on quality of life and patient involvement, and the role of emerging technologies, including artificial intelligence, in shaping future research.
Read the full interview.”
You can also read other articles featuring Benjamin Besse on OncoDaily.